Currently, there are 1.81B common shares owned by the public and among those 1.71B shares have been available to trade.
The company’s stock has a 5-day price change of 3.11% and 0.85% over the past three months. SCHW shares are trading 2.89% year to date (YTD), with the 12-month market performance up to 4.22% higher. It has a 12-month low price of $61.01 and touched a high of $84.50 over the same period. SCHW has an average intraday trading volume of 12.77 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.27%, -2.01%, and 4.31% respectively.
Institutional ownership of Charles Schwab Corp (NYSE: SCHW) shares accounts for 83.78% of the company’s 1.81B shares outstanding.
It has a market capitalization of $141.98B and a beta (3y monthly) value of 0.89. The stock’s trailing 12-month PE ratio is 23.15, while the earnings-per-share (ttm) stands at $3.29. The company has a PEG of 1.06 and the debt-to-equity ratio at 0.81. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.46% over the week and 3.88% over the month.
Analysts forecast that Charles Schwab Corp (SCHW) will achieve an EPS of 1.07 for the current quarter, 1.08 for the next quarter and 5.06 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.03 while analysts give the company a high EPS estimate of 1.03. Comparatively, EPS for the current quarter was 0.73 a year ago. Earnings per share for the fiscal year are expected to increase by 30.41%, and 19.24% over the next financial year. EPS should grow at an annualized rate of 21.85% over the next five years, compared to 2.26% over the past 5-year period.
Looking at the support for the SCHW, a number of firms have released research notes about the stock. Morgan Stanley stated their Overweight rating for the stock in a research note on April 08, 2025, with the firm’s price target at $76. Citigroup coverage for the Charles Schwab Corp (SCHW) stock in a research note released on April 02, 2025 offered a Buy rating with a price target of $102. TD Cowen was of a view on February 18, 2025 that the stock is Buy, while Wells Fargo gave the stock Overweight rating on January 22, 2025, issuing a price target of $89- $93. Barclays on their part issued Overweight rating on December 09, 2024.
